SC
BMY.RT

SRB Corp’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

SRB Corp’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,770
Closed -$4K – 171
2020
Q4 		$4K Hold
4,770
– – ﹤0.01% 158
2020
Q3 		$11K Hold
4,770
– – ﹤0.01% 145
2020
Q2 		$17K Hold
4,770
– – ﹤0.01% 143
2020
Q1 		$18K Buy
+4,770
New +$15.7K ﹤0.01% 169

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

SRB Corp's BMY.RT Position: Q1 2021 in Review

SRB Corp sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 4,770 shares — an estimated $4K sold.

SRB Corp first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $18K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • SRB Corp reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • SRB Corp sold 4,770 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $4K.
  • SRB Corp first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
  • SRB Corp's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $18K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on SRB Corp's 13F filing for Q1 2021, filed 14 May 2021.